Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Profectus BioSciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10841
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Profectus BioSciences Inc (Profectus) is a clinical-stage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company’s products include genevax therapeutic vaccines, vesiculovax prophylactic vaccines and additional prophylactic vaccines. It uses PBS Vax technology platform for the development of new vaccines. Profectus’ products are used in the treatment of major chronic infectious diseases of public health and biodefense. The company also develops vaccines for pre- and post-exposure protection against the hemorrhagic disease caused by ebola and marburg viruses. It also develops oncolytic vaccines for cancer immunotherapy. The company partners with research laboratories and universities. Profectus is headquartered in Baltimore, Maryland, the US.

Profectus BioSciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Profectus BioSciences Raises USD0.3 Million in Venture Financing 10
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 11
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 12
Profectus BioSciences Raises US$0.8 Million In Extended Series C Financing 13
Partnerships 14
CEPI Enters into Partnership with Profectus BioSciences and Emergent BioSolutions 14
CEPI Enters into Collaboration with Profectus BioSciences and Emergent BioSolutions 15
Profectus BioSciences Forms Joint Venture with Medisun Holdings 16
Profectus BioSciences Enters into Co-Development Agreement with Vyriad 17
Licensing Agreements 18
Profectus BioSciences Enters into Licensing Agreement with Henry M. Jackson 18
Profectus BioSciences Inc – Key Competitors 19
Profectus BioSciences Inc – Key Employees 20
Profectus BioSciences Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 22
Clinical Trials 22
Jan 09, 2017: Profectus BioSciences Bivalent Vaccine Protects Animals from Infection and Death After Exposure to Chikungunya or Zika Virus 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Profectus BioSciences Raises USD0.3 Million in Venture Financing 10
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 11
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 12
Profectus BioSciences Raises US$0.8 Million In Extended Series C Financing 13
CEPI Enters into Partnership with Profectus BioSciences and Emergent BioSolutions 14
CEPI Enters into Collaboration with Profectus BioSciences and Emergent BioSolutions 15
Profectus BioSciences Forms Joint Venture with Medisun Holdings 16
Profectus BioSciences Enters into Co-Development Agreement with Vyriad 17
Profectus BioSciences Enters into Licensing Agreement with Henry M. Jackson 18
Profectus BioSciences Inc, Key Competitors 19
Profectus BioSciences Inc, Key Employees 20
Profectus BioSciences Inc, Other Locations 21
Profectus BioSciences Inc, Joint Venture 21

List of Figures
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Celgene Corporation:企業の戦略・SWOT・財務情報
    Celgene Corporation - Strategy, SWOT and Corporate Finance Report Summary Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner), a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer component …
  • Frontera Energy Corp (FEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Frontera Energy Corp (Frontera), formerly Pacific Exploration & Production Corporation, is an upstream energy company. It carries out exploration, development and production of natural gas and crude oil. The company’s major assets include heavy oilfields of Quifa SW, Jaspe, Cajua, Quifa Nort …
  • Hitachi Zosen Corp (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corp (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Whirlpool Of India Limited:企業の戦略・SWOT・財務情報
    Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report Summary Whirlpool Of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • McCormick & Company Incorporated:戦略・SWOT・企業財務分析
    McCormick & Company Incorporated - Strategy, SWOT and Corporate Finance Report Summary McCormick & Company Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Blackthorn Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical stage biopharmaceutical company that discovers and develops targeted treatments for neurobehavioral disorders. The company offers products such as BTRX-246040, an NOPR antagonist; and BTRX-335140, a KOR antagonist. It uses I …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • Global Orthopaedic Technology Pty Ltd-医療機器分野:企業M&A・提携分析
    Summary Global Orthopaedic Technology Pty Ltd (Global) is an orthopaedic implant designer and manufacturer. The company offers orthopaedic implants for knee, hip and spine. Its hip products include global cup, bioball system, paragon stem, absolut cemented stem, and unisyn hip system among others. I …
  • Cascade Metrix LLC:製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that commercializes an automated POC blood analyzer for critical care. The company provides product portfolio such as novel micro-volume IV extension kits; and automated glucose monitoring systems, among others. It also provides a revo …
  • AutoZone, Inc.:企業の戦略・SWOT・財務分析
    AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • NCC Group PLC (NCC):企業の財務・戦略的SWOT分析
    NCC Group PLC (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mack-Cali Realty Corp (CLI):企業の財務・戦略的SWOT分析
    Mack-Cali Realty Corp (CLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ACWA Power Barka SAOG:発電所・企業SWOT分析
    ACWA Power Barka SAOG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Esterline Technologies Corporation:戦略・SWOT・企業財務分析
    Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Simulations Plus Inc (SLP)-医療機器分野:企業M&A・提携分析
    Summary Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides precli …
  • MLM Biologics Inc:製品パイプライン分析
    Summary MLM Biologics Inc (MLM Biologics) is a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for wounds such as chronic vascular ulcers, draining wounds, partial an …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の製品パイプライン分析2018
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • BirchBioMed Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BirchBioMed Inc (BirchBioMed) is a biomedical company that concentrate on the development, clinical evaluation and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company’s proprietary and patented lead drug candidate, FS2 is be …
  • MedX Health Corp (MDX):企業の財務・戦略的SWOT分析
    Summary MedX Health Corp (MedX) operates as a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆